--- a
+++ b/clusters/3009knumclusters/clust_285.txt
@@ -0,0 +1,459 @@
+Able to swallow and retain oral medication.
+Must be able to swallow pills
+Ability to swallow oral medications
+Patients must be able to swallow pills
+Able to swallow and retain oral medication (note: for patients unable to swallow tablets, an oral suspension preparation is acceptable)
+Patients must be able and willing to swallow and retain oral medication.
+Subject is able to swallow and retain oral medication and does not have uncontrolled emesis or gastrointestinal disorders likely to interfere with absorption of the study medication
+Patients must be able to swallow pills and must not have malabsorption problems or ongoing nausea and vomiting that would affect oral treatment
+Inability to swallow oral medications
+Patients must be able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patient is able to swallow, retain, and absorb oral medication
+Inability to swallow oral medications
+Able to swallow pills whole and retain oral medication
+Unable to swallow oral medications
+Able to swallow oral medication as an intact dosage form
+Subject must be able to swallow solid dosage forms.
+Patient must have the ability to swallow and retain oral medication
+Subject must be able to swallow and retain oral medication
+Ability to swallow oral medications
+Patients must be able to swallow and retain oral medication (intact tablet).
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain oral medication and no clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Ability to swallow, retain, and absorb oral medication
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain orally administered medication; does not have any clinically significant gastrointestinal abnormalities, such as malabsorption syndrome or major resection of the stomach or small bowel that may alter absorption of the medication
+Subjects must be able to swallow whole capsule.
+Participants who are unable to swallow or retain oral medication
+Patient must be able to swallow pills whole
+Subjects must have the ability to swallow and retain oral medication
+Ability to swallow and retain oral medication
+Subject is able to swallow pills.
+Any condition that may impact the subject's ability to swallow oral medications.
+Ability to swallow oral medications without difficulty.
+Participants who are unable to swallow or retain oral medication
+Ability to swallow the study drug as a whole tablet
+The ability to swallow pills and otherwise follow the protocol
+Participant must be able to swallow pills
+Able to swallow and retain oral medication
+Ability to swallow and retain oral medication
+Ability to swallow oral medications.
+Able to swallow oral medications
+Able to swallow and retain oral medication
+Participants must be able to swallow and retain oral medication or have an enteral feeding tube in place for study drug administration
+Participant is able to swallow a tablet whole
+Patient is able to swallow oral medications
+Ability to swallow the study drugs
+Able to swallow and retain oral medication if needed
+Must be able to swallow and retain oral medications
+Subject must be able to swallow and retain oral medication
+Subject must be able to swallow and retain oral medication
+Patients may or may not have neurological symptoms but must be able to swallow and retain oral medication. Be neurologically stable within at least 1 week prior to the first dose of study drug.
+The ability to swallow and retain oral medication
+Patient must be able to swallow and retain oral medication
+Ability to swallow and retain oral medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Ability to swallow and retain oral medication
+Able to swallow and retain oral medication
+Inability to swallow oral medications.
+Ability to swallow and retain oral medications
+Able to swallow oral medication.
+Ability to swallow and retain oral medication
+Able to swallow and retain oral medication
+Able to swallow and retain oral medications
+Able to swallow the study drug(s) whole as a tablet
+Ability to swallow oral medications
+Ability to swallow oral medications.
+Ability to be able to swallow and retain orally administered medication.
+Ability to swallow the study drug as a whole tablet.
+Able to swallow the study drug whole as a tablet
+Ability to swallow and retain oral medication
+Inability to swallow oral medications
+Patients must have the ability to swallow oral dosage forms
+Ability to swallow and retain oral medication.
+Ability to swallow and retain oral medication
+For Combination Therapy cohort only: Able to swallow pills.
+Patient must be able to swallow capsule or tablet
+Ability to swallow, retain, and absorb oral medication
+Patients that unable to swallow oral medications are ineligible
+Ability to be able to swallow and retain orally administered medication
+Able to swallow the study drug whole as a tablet.
+Able to swallow and retain oral medication, and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Able to swallow study drugs whole as a tablet/capsule.
+For oral cohorts: subject is able to swallow the oral capsule medication.
+Patients must be able to swallow and retain oral medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patients must be able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Ability to take oral medications (i.e. no feeding tube and able to swallow whole)
+Patients must be able to swallow and retain oral medications and be without gastrointestinal illnesses that would preclude absorption of AZD8186
+Ability to swallow and retain oral medication
+Able to swallow and retain orally administered medication; does not have any clinically significant gastrointestinal abnormalities, such as malabsorption syndrome or major resection of the stomach or small bowel that may alter absorption of the medication
+Patients must be able to swallow whole pills
+Must be able to swallow pills
+Inability to swallow or tolerate oral medication.
+Ability to swallow and retain oral medication
+Able to swallow study drug
+Able to swallow oral medication
+Subject must be able to swallow and retain oral medication
+Able to swallow and retain oral medication
+Participant must be able to swallow pills and retain oral medication and must not have clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Inability to swallow oral medications
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption, such as malabsorption syndrome or major resection of the stomach or bowels
+Patient must be able to swallow pills
+Patients must have the ability to swallow oral medications
+Able to swallow and retain oral medication
+Participants must be able to swallow oral pills
+Patients must be able and willing to swallow and retain oral medication without a condition that would interfere with enteric absorption
+Patient is not able to swallow pills
+Must be able to swallow ribociclib and oral aromatase inhibitor, such as letrozole
+Ability to swallow oral medications
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Ability to swallow oral medications
+Able to swallow oral medication as an intact dosage form
+Ability to swallow, retain, and absorb oral medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Any condition that impairs patient‘s ability to swallow whole pills
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Patient must be able to swallow pills
+Ability to swallow and retain oral medication
+Patients must be able to swallow pills
+Able to swallow oral medication
+Ability to swallow and retain oral medication
+Able to swallow the study drugs whole
+Able to swallow and retain orally-administered medication
+Ability to swallow oral medications
+Able to swallow the study drugs whole as a tablet
+Ability to swallow oral medications
+Patient is able to swallow and retain oral medication, unless approval per the manufacturer of other administration routes/methods is provided
+Able to swallow study drugs whole as a tablet/capsule
+Patients must be able to swallow and retain oral medication
+Patient must be able to swallow and retain oral medication
+Ability to swallow pills
+Subject must be able to swallow and retain oral medication
+Ability to swallow oral medications
+The subject must be able to swallow ribociclib (LEE011)
+Ability to swallow oral medications
+Ability to swallow and retain orally-administered medication and does not have any clinically significant gastro-intestinal abnormalities (e.g., malabsorption syndrome or major resection of the stomach or bowel)
+Subject must be able to swallow and retain oral medication
+Able to swallow pills
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Must be able to swallow pills.
+Inability to swallow medication
+Patients must be able to swallow and retain oral medication
+Patients must be able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib or olaparib
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Unable to swallow medication
+Able to swallow oral medications
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Must be able to swallow oral medications
+Patient has the ability to swallow oral medication and keep a pill diary
+Patients must have the ability to swallow oral medication.
+Ability to swallow and retain oral tablets
+Ability to swallow oral medications
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patient is able to swallow and retain oral medication
+Able to swallow pills
+Patient is able to swallow and retain oral medication
+Able to swallow and retain oral medication, and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow oral medications.
+Patients must have the ability to swallow pills
+Unable to swallow medication or suspected malabsorption
+Unable to swallow and retain oral medications
+Patient must be able to swallow pills
+Any condition that impairs patient‘s ability to swallow whole pills
+Willing to take abiraterone acetate on an empty stomach, and should be able to swallow tablets whole, without crushing/chewing tablets; must have the ability to swallow, retain, and absorb oral medication
+Must be able to swallow pills
+Able to swallow and retain orally-administered medication with no clinically significant gastrointestinal abnormalities that may alter absorption
+Can take or swallow medication orally i.e. no chronic or persistent nausea and vomiting
+Ability to swallow pills
+Willing and able to swallow and retain oral medication. Other protocol defined Inclusion criteria may apply.
+Ability to swallow an oral solid-dosage form of medication
+Ability to swallow an oral solid-dosage form of medication
+Ability to swallow an oral solid-dosage form of medication
+Unable to swallow oral medication.
+Able to take and retain oral medications
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patient is able to swallow and retain oral medication and does not have any clinically significant gastrointestinal abnormalities that may alter drug absorption, such as malabsorption syndrome or major resection of the stomach or bowels.
+Ability to swallow and retain oral medication, with no clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patient is able to swallow and retain oral medication
+Subject must be able to swallow and retain oral medication
+Able to swallow and retain oral medication
+Able to swallow and retain orally administered medication
+Patients must be able to swallow oral medications
+Patients must have the ability to swallow and retain oral medication
+Patients must be able to swallow oral medication
+Inability to swallow medication
+Able to swallow and absorb the medication
+Able to swallow and retain oral medication
+Patients must be able to swallow pills
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow oral medication
+Patient must be able to reliably swallow oral medications
+Ability to swallow and retain oral medication
+Able to swallow or have medication administered through a gastrostomy tube (G-tube) and absorb the medication
+Participants must be able and willing to swallow pills and to absorb oral medications
+Patient is unable to swallow or keep down oral medication
+Ability to swallow oral medications
+Able to swallow and retain oral medications and without gastrointestinal (GI) illnesses that would preclude absorption of cediranib or olaparib
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Ability to swallow and retain oral medication
+Able to swallow or have medication administered through a gastrostomy (G)-tube and absorb the medication
+Willingness and ability to swallow study drugs
+Patients must be able to swallow and retain oral medication
+Patient is able to swallow and retain oral medication
+Subject is able to swallow and retain oral medicines
+Patient is able to swallow and retain oral medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patients must be able to swallow and retain orally-administered medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patients must be able to swallow the drug
+Patients must be able to swallow pills
+Patient must be able to swallow pills
+PHASE II: Patient must be able to swallow pills
+Patient must have the ability to swallow and retain orally administered medication
+Patients are able to swallow and retain oral medication (i.e., no uncontrolled vomiting, inability to swallow, or diagnosis of chronic malabsorption)
+Patient must be able to swallow pills
+Any condition that impairs the patient’s ability to swallow whole pills
+Participants must be able to swallow oral medications
+Patient must be able to swallow pills
+Patient must be able to swallow oral medications
+Patients must be able to swallow medication by oral route
+Patient must be able to swallow and retain oral medication
+For subjects to be enrolled in Cohort 4: Able to swallow and retain orally administered tablets
+Patients must be able to swallow and retain oral medication
+Ability to swallow oral medication
+Ability to swallow and retain oral tablets
+Inability to swallow oral medication
+Patients with a bowel obstruction or any other gastrointestinal condition that might affect absorption of the oral drug should be excluded; this would include patients with inability to swallow and retain orally-administered medication, malabsorption syndrome, or those with a major resection of the stomach or bowels
+Patients must be able to swallow and retain orally-administered medication
+Inability to swallow or absorb orally-administered medication.
+Patients must be able to swallow whole capsule
+Ability to swallow study medication
+Ability to swallow and retain oral medication
+Able to swallow oral formulation of the study agent
+Unable to swallow and retain orally administered medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+The patient must be able to swallow oral medication.
+Ability to swallow and retain oral medication
+Impaired ability to swallow oral medication
+Subject cannot reliably swallow pills
+Subject must be able to swallow and retain oral medication
+Patient is able to swallow and retain oral medication
+Subject must be able to swallow and retain oral medication.
+Able to swallow oral medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Are able to swallow oral medications.
+All study participants must be able to swallow oral medication
+Able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib or olaparib
+For orally administered drugs, the patient must be able to swallow and tolerate oral medication and must have no known malabsorption syndrome
+Patient must be able to swallow and retain oral medication
+Ability to swallow and retain oral medication
+Patients who are unable to swallow oral medication are not eligible
+Participant must be able to swallow pills
+Subject must be able to swallow and retain oral medication
+Patient is able to swallow and retain oral medications
+Are able to swallow oral medication.
+Patients must be able to swallow and retain oral medication
+Able to swallow and retain orally administered medication.
+Participant has an impaired ability to swallow oral medication.
+Participant must be able to swallow pills
+Subject must be able to swallow and retain oral medication
+Subject has an impaired ability to swallow oral medication.
+Patients unable to swallow oral medications
+Able to swallow pills
+Patients who cannot swallow pills
+Ability to swallow oral medication
+Patients must have the ability to swallow oral medication.
+Patient is able to swallow and retain oral medication
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Ability to swallow and retain oral medication
+Patients must be able to reliably take and swallow oral medications
+Able to swallow and retain oral medications and begin therapy within 6 to 12 weeks post-surgery
+Patient must be able to swallow and retain oral medications
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Able to swallow the study drug as a whole tablet
+Patients must be able to swallow oral medication
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patient should be able to swallow and retain oral medications
+Ability to swallow and retain oral medications.
+Subject must be able to swallow and retain oral medication
+Able to swallow pills
+Subject must be able to swallow and retain oral medication
+Patient must be able to swallow capsule or tablet
+Any condition that impairs patient‘s ability to swallow whole pills
+Subject must be able to swallow and retain oral medication
+Patient must be able to swallow and retain oral medication
+Able to swallow the study drug whole as a tablet
+Ability to swallow oral medications
+Must be able to swallow whole pills
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow the study drug whole as a tablet
+Patients must have the ability to swallow oral medication.
+Are able to swallow and retain oral tablets
+Ability to swallow liquids
+Able to swallow and retain oral medication
+Ability to swallow and retain oral medications.
+Has the ability to swallow and retain oral medication and not have any clinically significant gastrointestinal abnormalities that might alter absorption.
+Is unable to swallow oral medication
+Able to swallow and retain oral medication
+Able to swallow the study drug whole as a tablet
+Ability to swallow, retain, and absorb oral medication
+Ability to swallow and retain oral medications
+Ability to swallow and retain oral medications
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Subject must be able to swallow and retain oral medication
+Ability to swallow oral medication
+Subject must be able to swallow and retain oral medication
+Any condition that impairs patient's ability to swallow whole pills
+Patient must be able to swallow pills
+Patients must be able to swallow and retain oral medication
+Patient is not able to swallow oral medication
+Able to swallow the study drug whole as a tablet
+Ability to swallow and retain oral medication
+Subject must be able to swallow and retain oral medication
+Patients unable to swallow oral medications.
+Able to swallow the study drug whole as a tablet
+Able to swallow and absorb the medication
+Patient is not able to swallow oral medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patients must be able to swallow and retain oral medication
+Ability to swallow pills and keep medication record
+Able to swallow and retain oral medication
+The ability to swallow pills
+Able to swallow and retain oral medication
+Patient is not able to swallow oral medication
+Continued ability to swallow and retain orally administered study treatment(s) and does not have any clinically significant GI abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Ability to swallow and retain oral medication
+Patients must be able to safely swallow pills.
+Ability to swallow and retain oral medication
+Able to swallow and retain oral medications
+Ability to swallow oral medication
+Ability to swallow oral medication
+Continued ability to swallow and retain orally administered study treatment(s) and does not have any clinically significant GI abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Inability to swallow or retain oral medication
+Able to swallow and retain oral medication;
+Inability to swallow oral medications
+The ability to swallow and retain oral medication
+Patients must be able to swallow pills
+Patients must be able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Continued ability to swallow and retain orally administered study drug(s) and does not have any clinically significant GI abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow oral medications
+EXPANSION COHORT ONLY: Able to swallow oral medications
+The participant is able to swallow oral medications.
+Participant must be able to swallow and retain oral medication
+Ability to swallow oral medicines.
+Ability to swallow and retain oral medications;
+Patient must be able to swallow pills
+Unable to swallow medication
+Unable to swallow medication; suspected malabsorption
+Any condition that impairs patient’s ability to swallow pills will make patient ineligible
+Ability to swallow oral medications
+Able to swallow medication
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patient must be able to swallow pills
+Must be able to swallow and retain oral medication.
+Patients must be able to swallow whole pills
+Ability to swallow oral medications
+Able to swallow the study drugs whole.
+Able to swallow pills
+Patients are able to swallow and retain oral medication
+Ability to swallow medication
+Subject must be able to swallow and retain oral medication
+Able to swallow and retain oral medication
+Subject must be able to swallow and retain oral medication
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Subject must be able to swallow medication
+Patient verbalizes the ability to swallow and retain oral medication
+Participants must be able to swallow pills to participate in the study
+Ability to swallow oral medications.
+Ability to swallow oral medication
+Able to swallow and retain oral medication.
+Must be able to take and retain oral medications.
+Patients must be able to swallow and tolerate oral medications
+Patients must be able to swallow oral medications
+Ability to swallow oral medications
+Ability to swallow the study drugs whole.
+Able and willing to swallow and retain oral medication.
+Able and willing to swallow and retain oral medication.
+Participant must be able to swallow and retain orally administered study treatment
+History of gastrointestinal disorder or defect. Impaired ability to swallow oral medication. Persistent diarrhea or malabsorption.
+Able to swallow and retain oral medication
+Inability to swallow oral medications
+Patient is able to swallow and retain oral medications
+Patients with malabsorption syndrome or other condition that would interfere with intestinal absorption or ability to swallow oral medication
+Able to swallow and retain orally administered medication
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow and retain oral medication
+Patients unable to swallow and retain oral medications
+Ability to swallow and retain oral medication
+Ability to swallow study drug whole as a capsule
+Able to swallow and retain orally administered study treatment and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Inability to swallow oral medications
+Able to swallow and retain enterally (per oral [PO] or nasogastric or gastric tube) administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
+Subject must be able to swallow and retain oral medication
+Patients must be able to swallow and retain oral medication
+Patients with malabsorption syndrome or other condition that would interfere with intestinal absorption of pills; patients must be able to swallow pills
+Patient must be able to swallow oral medications to be eligible for study enrollment
+Able to swallow the study drug whole as a tablet
+Any condition that severely impairs patient’s ability to swallow whole pills
+Ability to swallow oral medications;
+Ability to swallow oral medication
+Any condition that impairs patient‘s ability to swallow whole pills
+Any condition that impairs patient‘s ability to swallow whole pills
+Male or female age 18 years or greater; able to swallow and retain oral medication.
+Are able to swallow and retain oral medication.
+Any condition that impairs patient‘s ability to swallow whole pills
+Able to swallow and retain oral medications;
+Ability to swallow and retain oral medication
+Patients must be able to swallow pills
+Ability to swallow oral medications
+Patient is able swallow and absorb oral medications
+Ability to swallow and retain oral medication
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Able to swallow pills
+Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Ability to swallow the study drugs
+Patient is able to swallow and retain oral medication
+Patient is able to swallow and retain oral medication
+Able to swallow the study drug (no contraindication to oral agents).
+Able to swallow the study drug (no contra indication to oral agents).
+Able to swallow the study drug whole as a tablet
+Able to swallow thin liquids
+Able to swallow oral medications
+Patients unable to swallow oral medications
+Able to swallow supplements
+Inability to swallow study medication
+Ability to swallow and retain oral medication or take through a feeding tube
+Subject must be able to swallow and retain oral medication
+Ability to swallow oral medications
+Inability to swallow oral medications
+Able to swallow and retain oral medication
+Patients must be able to swallow pills
+Demonstrate the ability to swallow and retain oral medication
+Able to swallow medication
+Patient is able to swallow and retain oral medication
+Able to swallow oral medications
+Patients must have the ability to swallow oral medication
+Patients must be able to swallow and retain oral medication
+Participant must be able to swallow pills
+Participants must be able to swallow the oral doses of erlotinib and PPE
+Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Patients must be able to swallow pills
+Ability to swallow an oral solid-dosage form of medication
+Unable to swallow orally administered medication whole.
+Ability to swallow and retain oral medication
+Able to swallow pills
+Patient is able to swallow a capsule
+Ability to swallow study medication
+Demonstrate the ability to swallow and retain oral medication
+Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
+Ability to swallow pills
+Able to swallow oral medications
+Be able to swallow medication
+Ability to swallow and retain oral medication.
+Patients ability to swallow oral medication